## 참고문헌

10. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
11. Sawyer G, Miles J, Lewis S, Fitzharris P, Pearce N, Beasley R. Classification of asthma severity: should the international guidelines be changed? Clin Exp Allergy. 1998;28(12):1565-1570.
12. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax. 1992;47(3):162-166.
13. Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2 Suppl):18s-24s.
14. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. The Journal of allergy and clinical immunology. 1992;89(1 Pt 1):23-30.
15. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. The Journal of allergy and clinical immunology. 1985;75(5):573-577.
16. van Haren EH, Lammers JW, Festen J, Heijerman HG, Groot CA, van Herwaarden CL. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respiratory medicine. 1995;89(3):209-214.
17. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax. 1984;39(12):912-918.
18. Pizzichini MM, Popov TA, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. American journal of respiratory and critical care medicine. 1996;154(4 Pt 1):866-869.
19. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997;10(7):1683-1693.
20. American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American journal of respiratory and critical care medicine. 2005;171(8):912-930.
21. British guideline on the management of asthma. 2019.
22. Dweik RA, Boggs PB, Erzuruim SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. American journal of respiratory and critical care medicine. 2011;184(5):602-615.
23. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: National Institutes of Health, National Heart, Lung, and Blood Institute. 2007.
24. Global strategy for asthma management and prevention: NHLBI/WHO Workshop report: National Heart, Lung and Blood Institute; National Institutes of Health. 2014;May 2014.
25. Bacharier LB SR, Mauger D, White D, Lemanske Jr RF, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. American journal of respiratory and critical care medicine. 2004;170:426-432.
26. Colice GL BJ, Song J, Stampone P, Thompson PJ. Categorizing asthma severity. American journal of respiratory and critical care medicine. 1999;160:1962-1967.
27. Fuhlbrigge AL AR, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. American journal of respiratory and critical care medicine. 2002;166:1044-1049.
28. Llewelin P SG, Lewis S, Cheng S, Weatherall M, Fitzharris P, Beasley R. The relationship between FEV₁ and PEF in the assessment of the severity of airways obstruction. Respirology. 2002;7(4):333-337.
29. Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV₁ is associated with risk of asthma attacks in long-term follow-up. Chest. 2004;126(6):1875-1882.
30. Cowie RL, Underwood MF, Revitt SG, Field SK. Predicting emergency department utilization in adults with

<PAGE>63